VC Investment Agreements for BioMedTech Entrepreneurs

Speakers

Speaker's Profile:

Dr Yen Choo is Executive Director of co11ab and Associate Professor of Stem Cell Science and Regenerative Medicine at Lee Kong Chian School of Medicine (LKC Medicine), a joint medical school of Nanyang Technological University (NTU) and Imperial College London. Assoc. Prof. Choo is a serial bioentrepreneur with over 20 years of C-level and Board experience in establishing early-stage biotechnology ventures. Assoc Prof Choo was the founder and CSO of Gendaq, the biotechnology company that developed the zinc finger DNA-binding technology used for gene editing (acquired by Sangamo Therapeutics). He was the founder and CEO of Plasticell, one of the UK’s pioneering advanced therapy companies based on combinatorial stem cell screening technologies. He was also the founder and CEO of Progenitor Therapeutics, a small molecule therapeutics company established jointly with GSK to discover drugs that regenerate tissues of the human body.

Speaker's Profile:

Jason oversees the legal facets of venture building at ClavystBio, bringing his legal expertise and entrepreneurial experience to guide business strategy, venture capital financing and public private partnerships. Having been with multiple start-ups, Jason has a deep understanding of the needs of founders and early-stage companies, and is sensitive in navigating board and shareholder dynamics. Previously General Counsel at a leading biotech start-up in the cell and gene space, Jason was instrumental in orchestrating its largest fundraise of US$100+M and executed a carve-out of its manufacturing operations. While General Counsel at V-Key, a cybersecurity and fintech start-up, he implemented a channel partner strategy resulting in hyper-growth across 3 regions. Jason holds a BA in Jurisprudence from Oxford University, UK, and an MBA from INSEAD, France. He is also a Kellogg School of Management alumnus (USA exchange program).

Speaker's Profile:

Srinivas is the co-founder and CEO of Trisail Medical, a spin-off from the National Heart Centre Singapore, developing a cardiac implantable device to treat tricuspid regurgitation. He is also the founder & chairman of Intellimed Healthcare, a company focussed on commercializing innovative products in the Cardio and vascular space, including chronic wounds, in the ASEAN market, enabled by a digital health platform that empowers GPs and specialists through collaboration to achieve better outcomes for their patients. His other experiences include founding a startup in the board game space, working as CEO and MD of UCT Additive manufacturing and Anatomics Asia, which specialized in 3D printed custom made surgical tools and implants in Neuro and Ortho areas, and ~8 years in business development & licensing at A*STAR and NUS ILO.

Speaker's Profile:

Cairan He is Director of Investor Relations & Partnership at Ventureblick, an all-in-one healthcare innovation platform, incubating, investing in, scaling and consulting to innovative healthcare start-up’s. Cairan has had a career in both science and its commercialisation. He obtained his PhD focusing on Semiconductor Manufacturing Technology from Imperial College. He then worked at A*STAR as both a scientist and industry development manager and then with NUS in its technology commercialisation office. Cairan is active in the IP valuation and licensing communication having lectured at NUS on these aspects as well as having held key roles in various industry bodies such as Biotech Connection and the Licensing Executives Society, Singapore.

Moderator's Profile:

Faith Sing is an experienced corporate and commercial lawyer and the Managing Director of fsLAW. She is ranked as a leading lawyer by Chambers and asialaw Profiles. Faith has over 25 years'​ experience helping clients successfully structure, negotiate and document corporate and commercial deals, completing transactions with a combined value exceeding US$30 billion. Faith also set up a legal department, as the first General Counsel of Aspen Pharmacare Australia and worked in top corporate law firms in Sydney and London including Herbert Smith Freehills and Linklaters, including working on complex and innovative transactions requiring cutting-edge technical excellence.